Articles

Podcasts

Videos

The investigational therapy demonstrated time to first resolution of the five COVID-19 symptoms was significantly reduced in those treated with low dose of medication. 

Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill

C diff patients live in fear of a recurrence, says gastroenterologist Paul Feuerstadt, MD. RBX2660 has entered the FDA pipeline and looks to end this vicious cycle.

RBX2660 Could Heal Recurrent C Diff Patients, Physically and Psychologically

A European panel of experts endorsed the FDA’s recommendations. 

FDA Warns of Potential Monkeypox Transmission via FMT, Implements Additional Protections

Interim data show a bivalent vaccine that contains the Omicron variant may be more effective.

Bivalent SARS-CoV-2 Vaccine Might Offer Better Omicron Protection

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis  of Humeral Head

Uganda’s first Ebola outbreak in a decade raises concern due to its vaccine resistance.

Uganda Declares Ebola Outbreak Caused by Sudan Virus

With an all-ready challenging patient population to treat, having a program to get more people into treatment can be helpful in an underserved group.

Non-Targeted Screening Program Could Identify More HCV Infections 

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship 

A fecal microbiota transplant (FMT) trial was halted early due to clear evidence the treatment was superior to placebo.

FMT Trial Halted Early Due to Clear Efficacy for Recurrent C Difficile

These vaccines target the wild strain as well as the Omicron BA.4/BA.5 variants.

All News

Latest News